concept

QUERCETIN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about QUERCETIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

369Connections

0Hypotheses

1Analyses

50Outgoing

50Incoming

0Experiments

3Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	QUERCETIN
Key Genes/Proteins	ABCA1, ACHE, AKT, AKT1, AMPK, AMYLOID
Related Diseases	AGING, ALZHEIMER, Alzheimer Disease, Alzheimer'S Disease, ALZHEIMER'S DISEASE

Pathway Diagram

graph TD
    QUERCETIN["QUERCETIN"]
    QUERCETIN -.protects against.-> Diabetic_Nephropathy["Diabetic Nephropathy"]
    QUERCETIN -->|"inhibits"| Renal_Tubular_Epithelial_Cell_["Renal Tubular Epithelial Cell Apoptosis"]
    QUERCETIN -->|"inhibits"| Neuronal_Pyroptosis["Neuronal Pyroptosis"]
    QUERCETIN -->|"inhibits"| PI3K_AKT["PI3K/AKT"]
    QUERCETIN -->|"treats"| Cerebral_Ischemia_Reperfusion_["Cerebral Ischemia/Reperfusion Injury"]
    QUERCETIN -->|"regulates"| PI3K_Akt_NF__B_Signaling_Pathw["PI3K/Akt/NF-kappaB Signaling Pathway"]
    QUERCETIN -.protects against.-> HK_2_Cells["HK-2 Cells"]
    QUERCETIN -->|"modulates"| Microglial_M1_M2_Polarization["Microglial M1/M2 Polarization"]
    MICROGLIA["MICROGLIA"] -->|"inhibits"| QUERCETIN
    ENDOTHELIAL_CELLS["ENDOTHELIAL CELLS"] -->|"target for"| QUERCETIN
    DASATINIB["DASATINIB"] -->|"target for"| QUERCETIN
    CANCER["CANCER"] -->|"regulates"| QUERCETIN
    MACROPHAGES["MACROPHAGES"] -->|"activates"| QUERCETIN
    ISCHEMIA["ISCHEMIA"] -->|"activates"| QUERCETIN

Outgoing (234)

Target	Relation	Type	Str
Microglia M1/M2 Polarization	modulates	process	0.95
Cellular Senescence	inhibits	process	0.95
Nrf2/Ho1 Pathway	activates	pathway	0.95
TNF-α Induced Apoptosis	inhibits	process	0.95
Senescent Human Endothelial Cells	treats	cell_type	0.95
Microglia/Macrophages M2 Polarization	associated_with	process	0.95
Inflammation	inhibits	process	0.95
ROS	modulates	process	0.95
Renal Tubular Epithelial Cell Apoptosis	inhibits	process	0.95
Neuronal Pyroptosis	inhibits	process	0.95
Diabetic Nephropathy	protects_against	disease	0.95
PI3K/AKT	inhibits	pathway	0.93
NF-κB	downregulates	pathway	0.92
AP-1	downregulates	pathway	0.92
Cognitive Deficits	treats	phenotype	0.92
Senescent Cells	targets	cell_type	0.90
NF-κB	inhibits	protein	0.90
ANTIOXIDANT DEFENSE	activates	mechanism	0.90
Alzheimer'S Disease	treats	disease	0.90
Cerebral Ischemia/Reperfusion Injury	treats	disease	0.90
NFE2L2	activates	gene	0.90
PI3K/Akt/NF-κB Signaling Pathway	regulates	pathway	0.90
ALZHEIMER'S DISEASE	treats	disease	0.90
ferroptosis	inhibits	process	0.90
Neuroinflammation	inhibits	process	0.90
Microglial M1/M2 Polarization	modulates	process	0.90
HK-2 Cells	protects_against	cell_type	0.90
Neurodegeneration	protects_against	process	0.85
Type 2 Diabetes Mellitus	contributes_to	disease	0.85
Neuroinflammation	protects_against	process	0.85
Infarct Volume	associated_with	biomarker	0.85
iron homeostasis	regulates	process	0.85
AMPK	activates	protein	0.85
INFLAMMATION	inhibits	process	0.85
DEMENTIA	treats	disease	0.85
Neurological Deficits	associated_with	disease	0.85
Antioxidant Activity	involved_in	mechanism	0.80
Anti-apoptotic Activity	involved_in	mechanism	0.80
Anti-inflammatory Activity	involved_in	mechanism	0.80
Cancer Signaling Pathways	modulates	pathway	0.80
senescent cells	associated_with	cell_type	0.80
PI3K/Akt/NF-κB	inhibits	pathway	0.80
Senescent cell survival	suppresses	process	0.80
JNK	binds_to	protein	0.80
IL-6	inhibits	protein	0.78
MYC	binds_to	gene	0.75
senescence	modulates	pathway	0.75
senolytic_therapy	associated_with	drug	0.75
JNK	interacts_with	protein	0.75
AMPK/SIRT1 Signaling Pathway	activates	pathway	0.75

Incoming (135)

Source	Relation	Type	Str
APP	activates	gene	0.70
MAPK	targets	gene	0.65
MACROPHAGE	protects_against	cell_type	0.65
NEURODEGENERATION	causes	disease	0.65
DIABETES	causes	disease	0.65
MICROGLIA	protects_against	cell_type	0.65
DIABETES	treats	disease	0.65
ALZHEIMER'S DISEASE	treats	disease	0.65
ALZHEIMER	treats	disease	0.65
Neuroinflammation	inhibits	process	0.50
AMYLOID	inhibits	gene	0.50
MICROGLIA	inhibits	cell_type	0.50
cancer	regulates	disease	0.50
cancer	associated_with	disease	0.50
CGAS-STING PATHWAY	associated_with	pathway	0.50
STING PATHWAY	associated_with	pathway	0.50
PHAGOCYTOSIS	associated_with	phenotype	0.50
MICROGLIAL ACTIVATION	associated_with	phenotype	0.50
COGNITIVE DECLINE	associated_with	phenotype	0.50
OXIDATIVE STRESS	associated_with	phenotype	0.50
SYNAPTIC LOSS	associated_with	phenotype	0.50
HIPPOCAMPUS	associated_with	brain_region	0.50
SENESCENCE	associated_with	phenotype	0.50
ASTROCYTES	associated_with	cell_type	0.50
FLAVONOIDS	decreases_risk	concept	0.50
LIPID PEROXIDATION	associated_with	phenotype	0.50
mTOR	inhibits	entity	0.50
Pyroptosis	inhibits	pathway	0.50
atherosclerosis	inhibits	disease	0.50
ferroptosis	inhibits	phenotype	0.50
Epithelial Cell	protects_against	cell_type	0.50
apoptosis	protects_against	process	0.50
Type 2 Diabetes	activates	disease	0.50
ENDOTHELIAL	associated_with	concept	0.50
ENDOTHELIAL CELLS	associated_with	concept	0.50
Pi3K	inhibits	pathway	0.50
apoptosis	inhibits	process	0.50
Epithelial Cell	inhibits	cell_type	0.50
Pi3K/Akt	inhibits	pathway	0.50
Nephropathy	inhibits	disease	0.50
PI3K/AKT PATHWAY	inhibits	concept	0.50
apoptosis	activates	process	0.50
Epithelial Cell	activates	cell_type	0.50
DIABETES MELLITUS	activates	concept	0.50
MAPK	associated_with	gene	0.50
Type 2 Diabetes	associated_with	disease	0.50
Alzheimer'S Disease	associated_with	disease	0.50
ALZHEIMER'S	associated_with	concept	0.50
EGFR	associated_with	gene	0.50
AKT1	associated_with	gene	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 1.000

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (3)

Multi-agent debates referencing this entity

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

Senescent cell clearance as neurodegeneration therapy

closed · Rounds: 3 · Score: 0.95 · 2026-04-04

Related Research

Hypotheses and analyses mentioning QUERCETIN in their description or question text

No additional research found